Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Nov 14, 2022--
The "Global Cheminformatics Market by Application, End-user, Company, and Region: Competition Forecast and Opportunities to 2027" report has been added to ResearchAndMarkets.com's offering.
The Global cheminformatics market is anticipated to observe an impressive growth in the forecast period. The major factors like increasing awareness of personalized medicine combined with unsustainable liability of chronic disease are propelling the growth of global cheminformatics market.
Moreover, due to the awareness of personalized drugs among people, a sudden increase in usage of stratified medicines has made a positive influence on the cheminformatics market.
Furthermore, the other factors which impel the growth of the market are increasing investments in research and development to validate potential drug candidates and effectively operate data generated in the course of molecular and atomic reactions. The advancements in the new drug discovery process is a contributing factor for the growth of the market as it helps to design targeted drugs which help to advance public health and care.
Increasing Awareness Pertaining to Personalized Medicines
The increased awareness regarding the personalized medicines and surge in chronic diseases is driving the Cheminformatics market growth, globally. Nowadays, people are aware of these precision drugs due to various initiatives such as The European Cancer Patient Coalition (ECPC) launched a campaign in 2018 to spread awareness regarding the personalized drugs and its function. Therefore, due to the awareness among people, demand for customized medicine is forecast to witness a positive impact on the Cheminformatics market.
Design and Developments
Cheminformatics primarily deals with the new drug discovery which helps to treat various diseases without any side effects, propelling the growth of global cheminformatics market. When these drugs are being synthesized, a vast amount of data is produced, which results in designing of a new drug molecule. Also, the leading market players are combining innovative information storage and retrieval technologies in cheminformatics.
In addition, advancements in drug developments process have driven the growth of the market as various modern drug development techniques are being used instead of traditional drug discovery method. For instance, In-silico techniques are being used instead of traditional animal testing models as this technique helps to forecast the toxicity and evaluate the risk linked to it. Therefore, these technological advancements and developments will bolster the growth of cheminformatics market globally in upcoming years.
Increasing Investments to Boost Cheminformatics Market
Various investments in research and development (R&D) projects are done which also fuels the demand for cheminformatics to validate potential drug candidates and effectively operate data generated during molecular reactions. For instance, in 2020, research and development expenditure on pharmaceutical companies in the Unites States was USD 91.1 billion.
Companies Mentioned
Report Scope
In this report, global cheminformatics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Cheminformatics Market, by Application:
Cheminformatics Market, by End-user:
Cheminformatics Market, by Region:
For more information about this report visit https://www.researchandmarkets.com/r/eu50u5
View source version on businesswire.com:https://www.businesswire.com/news/home/20221114005900/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH CHEMICALS/PLASTICS MANUFACTURING OTHER SCIENCE RESEARCH SCIENCE PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/14/2022 12:51 PM/DISC: 11/14/2022 12:52 PM
http://www.businesswire.com/news/home/20221114005900/en